HEALTH CONSULTATION
OLEAN WELL FIELD
OLEAN, CATTARAUGUS COUNTY, NEW YORK
Figure
New York State Department of Health
Procedure for Evaluating Potential Health Risks
for Contaminants of Concern
To evaluate the potential health risks from contaminants of concern associated with the Olean Well Field site, the New York State Department of Health assessed the risks for cancer and noncancer health effects.
Increased cancer risks were estimated by using site-specific information on
exposure levels for the contaminant of concern and interpreting them using cancer
potency estimates derived for that contaminant by the US EPA or, in some cases,
by the NYS DOH. The following qualitative ranking of cancer risk estimates,
developed by the NYS DOH, was then used to rank the risk from very low to very
high. For example, if the qualitative descriptor was "low", then the excess
lifetime cancer risk from that exposure is in the range of greater than one
per million to less than one per ten thousand. Other qualitative descriptors
are listed below:
|
Excess Lifetime Cancer Risk
|
|
|
Risk Ratio
|
Qualitative Descriptor |
| equal to or less than one in a million | very low |
| greater than one in a million to less than one in ten thousand |
low |
| one in ten thousand to less than one in a thousand |
moderate |
| one in a thousand to less than one in ten |
high |
| equal to or greater than one in ten | very high |
An estimated increased excess lifetime cancer risk is not a specific estimate of expected cancers. Rather, it is a plausible upper bound estimate of the probability that a person may develop cancer sometime in his or her lifetime following exposure to that contaminant.
There is insufficient knowledge of cancer mechanisms to decide if there exists a level of exposure to a cancer-causing agent below which there is no risk of getting cancer, namely, a threshold level. Therefore, every exposure, no matter how low, to a cancer-causing compound is assumed to be associated with some increased risk. As the dose of a carcinogen decreases, the chance of developing cancer decreases, but each exposure is accompanied by some increased risk.
There is general consensus among the scientific and regulatory communities on what level of estimated excess cancer risk is acceptable. An increased lifetime cancer risk of one in one million or less is generally considered an insignificant increase in cancer risk.
For noncarcinogenic health risks, the contaminant intake was estimated using
exposure assumptions for the site conditions. This dose was then compared to
a risk reference dose (estimated daily intake of a chemical that is likely to
be without an appreciable risk of health effects) developed by the US EPA, ATSDR
and/or NYS DOH. The resulting ratio was then compared to the following qualitative
scale of health risk:
|
Qualitative Descriptions for |
|
|
Ratio of Estimated Contaminant |
Qualitative Descriptor |
|
equal to or less than the |
minimal |
|
greater than one to five times |
low |
|
greater than five to ten times |
moderate |
|
greater than ten times the |
high |
Noncarcinogenic effects unlike carcinogenic effects are believed to have a threshold, that is, a dose below which adverse effects will not occur. As a result, the current practice is to identify, usually from animal toxicology experiments, a no-observed-effect-level (NOEL). This is the experimental exposure level in animals at which no adverse toxic effect is observed. The NOEL is then divided by an uncertainty factor to yield the risk reference dose. The uncertainty factor is a number which reflects the degree of uncertainty that exists when experimental animal data are extrapolated to the general human population. The magnitude of the uncertainty factor takes into consideration various factors such as sensitive subpopulations (for example, children or the elderly), extrapolation from animals to humans, and the incompleteness of available data. Thus, the risk reference dose is not expected to cause health effects because it is selected to be much lower than dosages that do not cause adverse health effects in laboratory animals.
The measure used to describe the potential for noncancer health
effects to occur in an individual is expressed as a ratio of
estimated contaminant intake to the risk reference dose. If
exposure to the contaminant exceeds the risk reference dose, there
may be concern for potential noncancer health effects because the
margin of protection is less than that afforded by the reference
dose. As a rule, the greater the ratio of the estimated
contaminant intake to the risk reference dose, the greater the
level of concern. A ratio equal to or less than one is generally
considered an insignificant (minimal) increase in risk.
ATSDR Public Health Hazard Categories
| Category | Definition | Criteria |
| A. Urgent public health hazard | This category is used for sites that pose an urgent public health hazard as the result of short-term exposures to hazardous substances. |
|
| B. Public health hazard | This category is used for sites that pose a public health hazard as the result of long-term exposures to hazardous substances. |
|
| C. Indeterminate public health hazard | This category is used for sites with incomplete information. |
|
| D. No apparent public health hazard | This category is used for sites where human exposure to contaminated media is occurring or has occurred in the past, but the exposure is below a level of health hazard. |
|
| E. No public health hazard | This category is used for sites that do not pose a public health hazard. |
|